Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs ; volume:18 ; number:1 ; day:14 ; month:1 ; year:2019 ; pages:1-12 ; date:12.2019
Malaria journal ; 18, Heft 1 (14.1.2019), 1-12, 12.2019
- Urheber
-
Tougan, Takahiro
Toya, Yuji
Uchihashi, Kinya
Horii, Toshihiro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12936-019-2642-0
- URN
-
urn:nbn:de:101:1-2019021923331793946999
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tougan, Takahiro
- Toya, Yuji
- Uchihashi, Kinya
- Horii, Toshihiro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
An in vitro toolbox to accelerate anti-malarial drug discovery and development
Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate
Anti-malarial effect of gum arabic
Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents
Anti-Malarial work in the Huleh Valley
Novel pantothenate derivatives for anti-malarial chemotherapy
Substandard anti-malarial drugs in Burkina Faso
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Towards optimal design of anti-malarial pharmacokinetic studies
Synergistic anti-malarial action of cryptolepine and artemisinins
Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
An in vitro toolbox to accelerate anti-malarial drug discovery and development
Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate
Anti-malarial effect of gum arabic
Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents
Anti-Malarial work in the Huleh Valley
Novel pantothenate derivatives for anti-malarial chemotherapy
Substandard anti-malarial drugs in Burkina Faso
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Towards optimal design of anti-malarial pharmacokinetic studies
Synergistic anti-malarial action of cryptolepine and artemisinins
Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
An in vitro toolbox to accelerate anti-malarial drug discovery and development
Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate
Anti-malarial effect of gum arabic
Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents
Anti-Malarial work in the Huleh Valley
Novel pantothenate derivatives for anti-malarial chemotherapy
Substandard anti-malarial drugs in Burkina Faso
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Towards optimal design of anti-malarial pharmacokinetic studies